Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bio-Path Holdings (NQ: BPTH ) 1.090 +0.020 (+1.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bio-Path Holdings < Previous 1 2 3 4 5 6 7 Next > Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules October 10, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 09, 2024 Via Benzinga Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules October 08, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire Nasdaq Surges Over 1%; DocuSign Shares Spike Higher October 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 08, 2024 Via Benzinga Crude Oil Falls Over 4%; US Trade Deficit Narrows In August October 08, 2024 Via Benzinga Exposures Fossil Fuels US Stocks Edge Higher; PepsiCo Cuts 2024 Revenue Outlook October 08, 2024 Via Benzinga ACHR, BPTH, PLUG, REGRF: October 08, 2024 Leaders Report Latest Advances Via News Direct Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer October 08, 2024 Bio-Path is advancing its obesity treatment BP1001-A and completing trials for BP1002 in acute myeloid leukemia, targeting resistance mechanisms in treatment. Preclinical studies for obesity are set... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session October 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 03, 2024 Via Benzinga Bio-Path Holdings Announces Publication in Biomedicines September 16, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24 September 04, 2024 Dallas, Texas--(Newsfile Corp. - September 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path... Via Newsfile Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference September 03, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session September 02, 2024 Via Benzinga What Happened With Bio-Path Stock Today? August 21, 2024 Bio-Path shares ended Wednesday's session slightly higher after the company provided an update from its ongoing Phase 1/1b clinical trial of BP1001-A. Via Benzinga Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors August 21, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire Bio-Path Holdings Reports Second Quarter 2024 Financial Results August 15, 2024 Conference Call to be Held Today at 8:30 A.M. ET From Bio-Path Holdings, Inc. Via GlobeNewswire BPTH Stock Earnings: Bio-Path Holdings Beats EPS for Q2 2024 August 14, 2024 BPTH stock results show that Bio-Path Holdings beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024 August 08, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire Bio-Path Holdings Provides Clinical Update and Expansion Plans July 08, 2024 From Bio-Path Holdings, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 18, 2024 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! Via InvestorPlace Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END Via FinancialNewsMedia Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase June 17, 2024 From FN Media Group LLC Via GlobeNewswire Onsemi Layoffs 2024: What to Know as Onsemi Cuts 1,000 Jobs June 14, 2024 Onsemi layoffs are a hot topic on Friday after the company announced plans to cut jobs and close down some of its sites on weak demand. Via InvestorPlace Topics Workforce Exposures Layoff Why Bank of America Thinks Hasbro (HAS) Stock Can Gain 40% From Here June 14, 2024 Hasbro stock is up on Friday with a price target increase and rating upgrade for HAS shares from Bank of America analsyts. Via InvestorPlace Why Is Bio-Path (BPTH) Stock Up 20% Today? June 14, 2024 Bio-Path stock is up on Friday with heavy trading of NPTH shares after the company posited positive interim data from a Phase 2 study. Via InvestorPlace Why Bio-Path Stock Is Climbing Today June 14, 2024 Bio-Path Holdings shares are trading higher Friday after the company announced interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 14, 2024 Via Benzinga Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress June 14, 2024 Encore Presentation Highlights Positive Results from Interim Analysis Demonstrating Significant Clinical Improvement and Tolerable Safety Profile for Prexigebersen Combination in High-Risk Patients From Bio-Path Holdings, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.